Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.

Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Along with tafamidis and acoramidis, the drug is now the third for ATTR-CM, but it comes with a whopping price tag of ...

The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...

Home > Pressemitteilung: Major Progress in the Development of ...

Würzburg researchers present a new strategy against the life-threatening fungus Aspergillus fumigatus. They combine RNA ...

Healthee, a leader in AI-driven health benefits navigation, is expanding its employer-focused value proposition through a new partnership with Northwind Pharmaceuticals, a transparent pass-through ...

ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...

The US biotech has just reported phase 2 trial results with the small, interfering RNA (siRNA) gene-silencing drug showing that it an cause a 90% or greater reduction in Lp(a) levels – a risk ...

Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product ...

RNA therapies that switch off genes – sometimes referred to as small, interfering RNA (siRNA) drugs – have emerged as an important new class of drugs, but MiNA thinks it is out in front with ...

Researchers from the Institute of Polymer Science and Engineering, National Taiwan University, have developed a smart gel ...